Guidance

Shingles vaccine (Shingrix®): patient group direction (PGD) template

PGD template for Shingrix® vaccine for immunocompromised individuals.

Applies to England

Documents

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template is to support the administration of Shingrix® vaccine in accordance with the national shingles immunisation programme.

Version 3 of the shingles PGD is valid from 1 September 2025 to 31 August 2028.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see ). Practitioners should follow local policy or procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and for the vaccine.

Updates to this page

Published 31 August 2021
Last updated 22 July 2025 show all updates
  1. Added version 3 바카라 사이트 see page 3 for change history.

  2. Removed link to Zostavax PGD because this has expired.

  3. Added version 2.00 바카라 사이트 see page 2 for change history.

  4. First published.

Sign up for emails or print this page